ANAVEX LIFE SCIENCES CORP. Gains (Losses) on Restructuring of Debt
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Gains (Losses) on Restructuring of Debt of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRestructuringOfDebt · last filed 2020-12-28
- ANAVEX LIFE SCIENCES CORP. gains (losses) on restructuring of debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ANAVEX LIFE SCIENCES CORP. gains (losses) on restructuring of debt for fiscal 2019 was $115.76K.
| Period end | Gains (Losses) on Restructuring of Debt 12 month |
|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-12-28 |
| 2019-09-30 | $115.76K 10-K · filed 2020-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |